新型三氟甲基查耳酮类衍生物的设计、合成及体外抗宫颈癌活性

玉苏普瓦吉木·阿力木江; 艾孜提艾力·艾海提; 木合布力·阿布力孜; 杨争; 赛力克阿拉·阿里汗; 刘正叶

doi:10.11665/j.issn.1000-5048.20220605

新型三氟甲基查耳酮类衍生物的设计、合成及体外抗宫颈癌活性

新疆医科大学药学院，乌鲁木齐 830011

基金项目: 国家自然科学基金资助项目（No.81960625）；新疆天然药物活性组分与释药技术重点实验室资助项目（No.XJDX1713）

计量
- 文章访问数: 196
- HTML全文浏览量: 16
- PDF下载量: 349
出版历程
- 收稿日期: 2022-10-12
- 修回日期: 2022-11-17
- 刊出日期: 2022-12-24

Design, synthesis and anti-cervical cancer activity of novel trifluoromethyl chalcones derivatives

College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China

Funds: This study was supported by the National Natural Science Foundation of China (No.81960625); and the Project of Xinjiang Key Laboratory of Natural Medicine Active Components and Drug Release Technology (No.XJDX1713)

摘要

摘要: 查耳酮类化合物是一种多酚类黄酮物质，具有多种药理活性，毒性较低。本研究以天然甘草查耳酮母核为先导化合物骨架，设计合成了15个新型三氟甲基查耳酮类衍生物（3a ~ 3o）。目标化合物结构经¹H NMR、¹³C NMR和HRMS进行确认。采用MTT法测定化合物3a ~ 3o、甘草查耳酮、顺铂和Nutlin3a对SiHa、HeLa、C-33A等3种人宫颈癌细胞和H8、HaCaT等两种正常细胞的增殖抑制活性，并进行构效关系分析；采用Transwell法和流式细胞仪法评价目标化合物抑制癌细胞迁移侵袭、促凋亡、阻滞细胞周期的能力。通过分子对接技术研究目标化合物与Akt-MDM2-p53通路中MDM2蛋白的结合特征。结果显示，目标化合物对3种宫颈癌细胞的增殖具有不同程度的抑制活性。其中，化合物3n对HeLa细胞的活性最强（IC₅₀= 11.69 μmol/L），明显优于先导化合物，并对两种正常细胞的毒性较低；化合物3n能显著抑制HeLa细胞的迁移和侵袭，诱导癌细胞凋亡，并将细胞周期阻滞在G₂/M期。分子对接结果显示，化合物3n能与MDM2蛋白有效结合（结合能为-38.1 kJ/mol），具有抑制MDM2蛋白作用。本研究为新型有效低毒的查耳酮类抗肿瘤候选药物筛选提供了实验依据。
- 查耳酮类 /
- 衍生物 /
- 合成 /
- 子宫颈癌 /
- 增殖抑制 /
- 凋亡 /
- 抗肿瘤活性
Abstract: Chalcones are polyphenolic flavonoid substances with various pharmacological effects and low toxicity.In this study, 15 novel trifluoromethyl chalcone derivatives (3a-3o) were designed and synthesized using the chalcone nucleus of natural licorice chalcone as the lead compound skeleton in order to find the candidate drugs with high efficiency and low toxicity against cervical cancer.The structures of the target compounds were confirmed by ¹H NMR, ¹³C NMR and HRMS. The inhibitory activities of compounds 3a-3o, licorice chalcone, cisplatin and Nutlin3a on SiHa, HeLa and C-33A human cervical cancer cells and H8 and HaCaT normal cells were determined by MTT assay, and the structure-activity relationship was analyzed.Transwell and flow cytometry methods were used to assess the target compounds' ability to inhibit cell migration and invasion, promote apoptosis, and arrest the cell cycle.Molecular docking technology was used to further study the binding characteristics of the target compound with MDM2 protein.The results showed that the compounds had different degrees of inhibitory activity against the three types of cervical cancer cells.Compound 3n showed the strongest activity against HeLa cells (IC₅₀= 11.69 μmol/L), which was superior to the lead compound, and had lower toxicity against the two normal cells.Compound 3n was found to significantly inhibit the migration and invasion of HeLa cells, induce apoptosis and arrest the cell cycle at G₂/M phase.The results of molecular docking showed that the effective binding of compound 3n to MDM2 protein may be one of its anti-tumor mechanisms.This study provides an experimental basis for the screening of new anti-cervical cancer candidate drug from chalcone derivatives.
- chalcone derivatives /
- synthesis /
- cervical cancer /
- proliferation inhibition /
- apoptosis /
- anti-tumor activity

HTML全文

参考文献(27)

[1]	. Int J Environ Res Public Health，2022，19（12）：7094.
[2]	di Fiore R，Suleiman S，Drago-Ferrante R，et al. Cancer stem cells and their possible implications in cervical cancer：a short review［J］. Int J Mol Sci，2022，23（9）：5167.
[3]	Sung H，Ferlay J，Siegel RL，et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin，2021，71（3）：209-249.
[4]	Liu ZC，Li ZX，Zhang Y，et al. Interpretation on the report of global cancer statistics 2020［J］. J Multidiscip Cancer Manag Electronic Version（肿瘤综合治疗电子杂志），2021，7（2）：1-14.
[5]	Dre?canu G，Iuhas CI，Diaconeasa Z. The involvement of natural polyphenols in the chemoprevention of cervical cancer［J］. Int J Mol Sci，2021，22（16）：8812.
[6]	He MZ，Xia LJ，Li JY. Potential mechanisms of plant-derived natural products in the treatment of cervical cancer［J］. Biomolecules，2021，11（10）：1539.
[7]	He XL，Liao YK，Liu J，et al. Research progress of natural small-molecule compounds related to tumor differentiation［J］. Molecules，2022，27（7）：2128.
[8]	Xiong JF，Li GN，Mei XY，et al. Co-delivery of p53 restored and E7 targeted nucleic acids by poly（beta-amino ester） complex nanoparticles for the treatment of HPV related cervical lesions［J］. Front Pharmacol，2022，13：826771.
[9]	Kooti A，Abuei H，Farhadi A，et al. Activating transcription factor 3 mediates apoptotic functions through a p53-independent pathway in human papillomavirus 18 infected HeLa cells［J］. Virus Genes，2022，58（2）：88-97.
[10]	Heijkants RC，Teunisse AFAS，de Jong D，et al. MDMX regulates transcriptional activity of p53 and FOXO proteins to stimulate proliferation of melanoma cells［J］. Cancers（Basel），2022，14（18）：4482.
[11]	Chinnam M，Xu C，Lama R，et al. MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity［J］. PLoS Genet，2022，18（5）：e1010171.
[12]	Zhang JW，Yu GH，Yang YT，et al. A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis［J］. Pharmacol Res，2022，177：106128.
[13]	Espadinha M，Lopes EA，Marques V，et al. Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors［J］. Eur J Med Chem，2022，241：114637.
[14]	Grinkevich VV，Vema A，Fawkner K，et al. Novel allosteric mechanism of dual p53/MDM2 and p53/MDM4 inhibition by a small molecule［J］. Front Mol Biosci，2022，9：823195.
[15]	de Souza PS，Bibá GCC，Melo EDDN，et al. Chalcones against the hallmarks of cancer：a mini-review［J］. Nat Prod Res，2022，36（18）：4809-4826.
[16]	Constantinescu T，Lungu CN. Anticancer activity of natural and synthetic chalcones［J］. Int J Mol Sci，2021，22（21）：11306.
[17]	Shukla S，Sood AK，Goyal K，et al. Chalcone scaffolds as anticancer drugs：a review on molecular insight in action of mechanisms and anticancer properties［J］. Anticancer Agents Med Chem，2021，21（13）：1650-1670.
[18]	Ouyang Y，Li JJ，Chen XY，et al. Chalcone derivatives：role in anticancer therapy［J］. Biomolecules，2021，11（6）：894.
[19]	Wang JC，Yang CB，Zhuo YL，et al. Recent advances of MDM2-p53 inhibitors［J］. Acta Pharm Sin（药学学报），2021，56（4）：983-995.
[20]	Si DJ，Luo HJ，Zhang XM，et al. Design，synthesis and biological evaluation of novel pyrrolidone-based derivatives as potent p53-MDM2 inhibitors［J］. Bioorg Chem，2021，115：105268.
[21]	Mireguli M. Preparation and anti-cervical cancer activity of glycyrrhiza inflata chalcones and its derivatives（胀果甘草查耳酮类活性成分及其衍生物的制备及抗宫颈癌活性研究）［D］. Xinjiang：Xinjiang Medical University，2020.
[22]	Liu LM，Wang ZJ，Gao C，et al. Design，synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives［J］. Bioorg Med Chem Lett，2021，51：128268.
[23]	Wang ZJ，Dai HL，Si XJ，et al. Synthesis and antitumor activity of 2，4，6-trisubstituted novel quinazoline derivatives containing trifluoromethyl［J］. Chin J Org Chem（有机化学），2022，42（1）：249-256.
[24]	Aizitiaili A，Yang Z，Mourboul A，et al. Synthesis and anti-cervical cancer activities of novel α-methyl chalcone derivatives［J］. Chin J Med Chem（中国药物化学杂志），2022，32（1）：8-18.
[25]	Yuan H，Zuo J，Li N，et al. Fronter research on drug treatment of gynecological oncology［J］. Chin J Cancer Prevention and Treatment（中华肿瘤防治杂志），2022，29（14）：1023-1032.
[26]	Islam F，Mitra S，Emran TB，et al. Natural small molecules in gastrointestinal tract and associated cancers：molecular insights and targeted therapies［J］. Molecules，2022，27（17）：5686.
[27]	Sun TZ. Mathematical modeling of the synergy between hyperthermia and radiotherapy in tumor treatment based on p53 signaling network［J］. J China Pharm Univ（中国药科大学学报），2021，52（3）：361-370.